Tuhura Biosciences Inc (HURA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,909 | 6,351 | N/A | 216 | 1,535 |
| Other current assets | 205 | 196 | 0 | 0 | 1,075 |
| TOTAL | $5,528 | $6,755 | $N/A | $783 | $3,270 |
| Non-Current Assets | |||||
| PPE Net | 674 | 691 | N/A | 694 | 709 |
| TOTAL | $674 | $691 | $N/A | $694 | $709 |
| Total Assets | $6,202 | $7,446 | $N/A | $1,477 | $3,979 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,259 | 1,341 | 0 | 3,336 | 3,082 |
| TOTAL | $2,259 | $1,341 | $N/A | $3,336 | $3,082 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 186 | 183 | 0 | 167 | 166 |
| TOTAL | $186 | $183 | $N/A | $167 | $166 |
| Total Liabilities | $2,445 | $1,524 | $N/A | $3,503 | $3,248 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | 1,582 | 1,116 | 97 | N/A |
| Common Shares | 2 | 55 | N/A | 2 | 2 |
| Retained earnings | -159,876 | -157,550 | N/A | -154,512 | -151,375 |
| Other shareholders' equity | 21 | 21 | 0 | 21 | 21 |
| TOTAL | $3,757 | $5,922 | $N/A | $-2,026 | $731 |
| Total Liabilities And Equity | $6,202 | $7,446 | $0 | $1,477 | $3,979 |